메뉴 건너뛰기




Volumn 7, Issue , 2015, Pages

Connective tissue disease-associated pulmonary arterial hypertension

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN RECEPTOR ANTAGONIST; PHOSPHODIESTERASE V INHIBITOR; PROSTANOID;

EID: 84921365652     PISSN: 20517599     EISSN: 20517599     Source Type: Journal    
DOI: 10.12703/P7-06     Document Type: Article
Times cited : (41)

References (77)
  • 10
    • 34248389766 scopus 로고    scopus 로고
    • Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases
    • Dorfmuller P, Humbert M, Perros F, Sanchez O, Simonneau G, Muller KM, Capron F: Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Hum Pathol 2007, 38:893-902.
    • (2007) Hum Pathol , vol.38 , pp. 893-902
    • Dorfmuller, P.1    Humbert, M.2    Perros, F.3    Sanchez, O.4    Simonneau, G.5    Muller, K.M.6    Capron, F.7
  • 13
    • 50949088213 scopus 로고    scopus 로고
    • Predictive value of antinuclear autoantibodies: The lessons of the systemic sclerosis autoantibodies
    • Koenig M, Dieude M, Senecal JL: Predictive value of antinuclear autoantibodies: The lessons of the systemic sclerosis autoantibodies. Autoimmun Rev 2008, 7:588-93.
    • (2008) Autoimmun Rev , vol.7 , pp. 588-593
    • Koenig, M.1    Dieude, M.2    Senecal, J.L.3
  • 18
    • 69949178696 scopus 로고    scopus 로고
    • Therapies for scleroderma-related pulmonary arterial hypertension
    • Hassoun PM: Therapies for scleroderma-related pulmonary arterial hypertension. Expert Rev Respir Med 2009, 3:187-96.
    • (2009) Expert Rev Respir Med , vol.3 , pp. 187-196
    • Hassoun, P.M.1
  • 19
    • 0037331671 scopus 로고    scopus 로고
    • Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement
    • Steen V, Medsger TA, Jr: Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 2003, 48:516-22.
    • (2003) Arthritis Rheum , vol.48 , pp. 516-522
    • Steen, V.1    Medsger, T.A.2
  • 20
    • 78649315195 scopus 로고    scopus 로고
    • Characterization of connective tissue disease-associated pulmonary arterial hypertension from reveal: Identifying systemic sclerosis as a unique phenotype
    • Chung L, Liu J, Parsons L, Hassoun PM, McGoon M, Badesch DB, Miller DP, Nicolls MR, Zamanian RT: Characterization of connective tissue disease-associated pulmonary arterial hypertension from reveal: Identifying systemic sclerosis as a unique phenotype. Chest 2010, 138:1383-94.
    • (2010) Chest , vol.138 , pp. 1383-1394
    • Chung, L.1    Liu, J.2    Parsons, L.3    Hassoun, P.M.4    McGoon, M.5    Badesch, D.B.6    Miller, D.P.7    Nicolls, M.R.8    Zamanian, R.T.9
  • 23
    • 77950261786 scopus 로고    scopus 로고
    • Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: A retrospective cohort study
    • Nihtyanova SI, Tang EC, Coghlan JG, Wells AU, Black CM, Denton CP: Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: A retrospective cohort study. QJM 2010, 103:109-15.
    • (2010) QJM , vol.103 , pp. 109-115
    • Nihtyanova, S.I.1    Tang, E.C.2    Coghlan, J.G.3    Wells, A.U.4    Black, C.M.5    Denton, C.P.6
  • 24
    • 32144461709 scopus 로고    scopus 로고
    • Natural history of mild-moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in scleroderma
    • Chang B, Schachna L, White B, Wigley FM, Wise RA: Natural history of mild-moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in scleroderma. J Rheumatol 2006, 33:269-74.
    • (2006) J Rheumatol , vol.33 , pp. 269-274
    • Chang, B.1    Schachna, L.2    White, B.3    Wigley, F.M.4    Wise, R.A.5
  • 30
    • 0029985117 scopus 로고    scopus 로고
    • Pulmonary hypertension in systemic sclerosis: An analysis of 17 patients
    • Koh ET, Lee P, Gladman DD, Abu-Shakra M: Pulmonary hypertension in systemic sclerosis: An analysis of 17 patients. Br JRheumatol 1996, 35:989-93.
    • (1996) Br JRheumatol , vol.35 , pp. 989-993
    • Koh, E.T.1    Lee, P.2    Gladman, D.D.3    Abu-Shakra, M.4
  • 31
    • 84885117137 scopus 로고    scopus 로고
    • Survival in systemic sclerosis with pulmonary arterial hypertension has not improved in the modern era
    • Rubenfire M, Huffman MD, Krishnan S, Seibold JR, Schiopu E, McLaughlin VV: Survival in systemic sclerosis with pulmonary arterial hypertension has not improved in the modern era. Chest 2013, 144:1282-90.
    • (2013) Chest , vol.144 , pp. 1282-1290
    • Rubenfire, M.1    Huffman, M.D.2    Krishnan, S.3    Seibold, J.R.4    Schiopu, E.5    McLaughlin, V.V.6
  • 34
    • 45249119855 scopus 로고    scopus 로고
    • Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (early study): A double-blind, randomised controlled trial
    • Galie N, Rubin L, Hoeper M, Jansa P, Al-Hiti H, Meyer G, Chiossi E, Kusic-Pajic A, Simonneau G: Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (early study): A double-blind, randomised controlled trial. Lancet 2008, 371:2093-100.
    • (2008) Lancet , vol.371 , pp. 2093-2100
    • Galie, N.1    Rubin, L.2    Hoeper, M.3    Jansa, P.4    Al-Hiti, H.5    Meyer, G.6    Chiossi, E.7    Kusic-Pajic, A.8    Simonneau, G.9
  • 37
    • 84875728533 scopus 로고    scopus 로고
    • Borderline mean pulmonary artery pressure in patients with systemic sclerosis: Transpulmonary gradient predicts risk of developing pulmonary hypertension
    • Valerio CJ, Schreiber BE, Handler CE, Denton CP, Coghlan JG: Borderline mean pulmonary artery pressure in patients with systemic sclerosis: Transpulmonary gradient predicts risk of developing pulmonary hypertension. Arthritis Rheum 2013, 65:1074-84.
    • (2013) Arthritis Rheum , vol.65 , pp. 1074-1084
    • Valerio, C.J.1    Schreiber, B.E.2    Handler, C.E.3    Denton, C.P.4    Coghlan, J.G.5
  • 40
    • 84870322299 scopus 로고    scopus 로고
    • Brief report: Effect of ambrisentan treatment on exercise-induced pulmonary hypertension in systemic sclerosis: A prospective singlecenter, open-label pilot study
    • Saggar R, Khanna D, Shapiro S, Furst DE, Maranian P, Clements P, Abtin F, Dua S, Belperio J, Saggar R: Brief report: Effect of ambrisentan treatment on exercise-induced pulmonary hypertension in systemic sclerosis: A prospective singlecenter, open-label pilot study. Arthritis Rheum 2012, 64:4072-7.
    • (2012) Arthritis Rheum , vol.64 , pp. 4072-4077
    • Saggar, R.1    Khanna, D.2    Shapiro, S.3    Furst, D.E.4    Maranian, P.5    Clements, P.6    Abtin, F.7    Dua, S.8    Belperio, J.9    Saggar, R.10
  • 44
    • 4143121167 scopus 로고    scopus 로고
    • Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease
    • Oudiz RJ, Schilz RJ, Barst RJ, Galie N, Rich S, Rubin LJ, Simonneau G: Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease. Chest 2004, 126:420-7.
    • (2004) Chest , vol.126 , pp. 420-427
    • Oudiz, R.J.1    Schilz, R.J.2    Barst, R.J.3    Galie, N.4    Rich, S.5    Rubin, L.J.6    Simonneau, G.7
  • 48
    • 84855358253 scopus 로고    scopus 로고
    • Pulmonary Arterial Hypertension Quality Enhancement Research Initiative I: The pulmonary arterial hypertension quality enhancement research initiative: Comparison of patients with idiopathic pah to patients with systemic sclero-sis-associated pah
    • Clements PJ, Tan M, McLaughlin VV,Oudiz RJ, Tapson VF, Channick RN, Rubin LJ, Langer A, Pulmonary Arterial Hypertension Quality Enhancement Research Initiative I: The pulmonary arterial hypertension quality enhancement research initiative: Comparison of patients with idiopathic pah to patients with systemic sclero-sis-associated pah. Ann Rheum Dis 2012, 71:249-52.
    • (2012) Ann Rheum Dis , vol.71 , pp. 249-252
    • Clements, P.J.1    Tan, M.2    McLaughlin, V.V.3    Oudiz, R.J.4    Tapson, V.F.5    Channick, R.N.6    Rubin, L.J.7    Langer, A.8
  • 49
    • 0037331116 scopus 로고    scopus 로고
    • Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis
    • Kawut SM, Taichman DB, Archer-Chicko CL, Palevsky HI, Kimmel SE: Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest 2003, 123:344-50.
    • (2003) Chest , vol.123 , pp. 344-350
    • Kawut, S.M.1    Taichman, D.B.2    Archer-Chicko, C.L.3    Palevsky, H.I.4    Kimmel, S.E.5
  • 60
    • 0037310652 scopus 로고    scopus 로고
    • Predictors of end stage lung disease in systemic sclerosis
    • Steen V: Predictors of end stage lung disease in systemic sclerosis. Ann Rheum Dis 2003, 62:97-9.
    • (2003) Ann Rheum Dis , vol.62 , pp. 97-99
    • Steen, V.1
  • 61
    • 59649103901 scopus 로고    scopus 로고
    • Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: Impact of interstitial lung disease
    • Mathai SC, Hummers LK, Champion HC, Wigley FM, Zaiman A, Hassoun PM, Girgis RE: Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: Impact of interstitial lung disease. Arthritis Rheum 2009, 60:569-77.
    • (2009) Arthritis Rheum , vol.60 , pp. 569-577
    • Mathai, S.C.1    Hummers, L.K.2    Champion, H.C.3    Wigley, F.M.4    Zaiman, A.5    Hassoun, P.M.6    Girgis, R.E.7
  • 62
    • 79960031695 scopus 로고    scopus 로고
    • Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: Clinical prevalence, outcomes, and mechanistic insights
    • Rhodes CJ, Howard LS, Busbridge M, Ashby D, Kondili E, Gibbs JS, Wharton J, Wilkins MR: Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: Clinical prevalence, outcomes, and mechanistic insights. J AmColl Cardiol 2011, 58:300-9.
    • (2011) J Amcoll Cardiol , vol.58 , pp. 300-309
    • Rhodes, C.J.1    Howard, L.S.2    Busbridge, M.3    Ashby, D.4    Kondili, E.5    Gibbs, J.S.6    Wharton, J.7    Wilkins, M.R.8
  • 64
    • 79954434925 scopus 로고    scopus 로고
    • Pulmonary hypertension in systemic lupus erythematosus: Relationship with antiphospholipid antibodies and severe disease outcome
    • Cefle A, Inanc M, Sayarlioglu M, Kamali S, Gul A, Ocal L, Aral O, Konice M: Pulmonary hypertension in systemic lupus erythematosus: Relationship with antiphospholipid antibodies and severe disease outcome. Rheumatol Int 2009, 31:183-9.
    • (2009) Rheumatol Int , vol.31 , pp. 183-189
    • Cefle, A.1    Inanc, M.2    Sayarlioglu, M.3    Kamali, S.4    Gul, A.5    Ocal, L.6    Aral, O.7    Konice, M.8
  • 65
    • 0028962676 scopus 로고
    • Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus
    • Winslow TM, Ossipov MA, Fazio GP, Simonson JS, Redberg RF, Schiller NB: Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus. Am Heart J 1995, 129:510-5.
    • (1995) Am Heart J , vol.129 , pp. 510-515
    • Winslow, T.M.1    Ossipov, M.A.2    Fazio, G.P.3    Simonson, J.S.4    Redberg, R.F.5    Schiller, N.B.6
  • 66
    • 33744822178 scopus 로고    scopus 로고
    • Epidemiology of systemic lupus erythematosus: A comparison of worldwide disease burden
    • Danchenko N, Satia JA, Anthony MS: Epidemiology of systemic lupus erythematosus: A comparison of worldwide disease burden. Lupus 2006, 15:308-18.
    • (2006) Lupus , vol.15 , pp. 308-318
    • Danchenko, N.1    Satia, J.A.2    Anthony, M.S.3
  • 67
    • 84872381980 scopus 로고    scopus 로고
    • Pulmonary hypertension in systemic lupus erythematosus: Prevalence, predictors and diagnostic strategy
    • Ruiz-Irastorza G, Garmendia M, Villar I, Egurbide MV, Aguirre C: Pulmonary hypertension in systemic lupus erythematosus: Prevalence, predictors and diagnostic strategy. Autoimmun Rev 2013, 12:410-5.
    • (2013) Autoimmun Rev , vol.12 , pp. 410-415
    • Ruiz-Irastorza, G.1    Garmendia, M.2    Villar, I.3    Egurbide, M.V.4    Aguirre, C.5
  • 69
    • 39749156384 scopus 로고    scopus 로고
    • Immunosuppressive therapy in lupusand mixed connective tissue disease-associated pulmonary arterial hypertension: A retrospective analysis of twentythree cases
    • Jais X, Launay D, Yaici A, Le Pavec J, Tcherakian C, Sitbon O, Simonneau G, Humbert M: Immunosuppressive therapy in lupusand mixed connective tissue disease-associated pulmonary arterial hypertension: A retrospective analysis of twentythree cases. Arthritis Rheum 2008, 58:521-31.
    • (2008) Arthritis Rheum , vol.58 , pp. 521-531
    • Jais, X.1    Launay, D.2    Yaici, A.3    Le Pavec, J.4    Tcherakian, C.5    Sitbon, O.6    Simonneau, G.7    Humbert, M.8
  • 70
    • 84859772546 scopus 로고    scopus 로고
    • Pulmonary arterial hypertension in systemic lupus erythematosus: Current status and future direction
    • Dhala A: Pulmonary arterial hypertension in systemic lupus erythematosus: Current status and future direction. Clin Dev Immunol 2012, 2012:854941.
    • (2012) Clin Dev Immunol , vol.2012 , pp. 854941
    • Dhala, A.1
  • 73
    • 84893190421 scopus 로고    scopus 로고
    • Pulmonary arterial hypertension in patients with primary sjogren's syndrome
    • Kobak S, Kalkan S, Kirilmaz B, Orman M, Ercan E: Pulmonary arterial hypertension in patients with primary sjogren's syndrome. Autoimmune diseases 2014, 2014:710401.
    • (2014) Autoimmune Diseases , vol.2014 , pp. 710401
    • Kobak, S.1    Kalkan, S.2    Kirilmaz, B.3    Orman, M.4    Ercan, E.5
  • 77
    • 84876831990 scopus 로고    scopus 로고
    • Pulmonary hypertension: Diagnosis and management
    • Kiely DG, Elliot CA, Sabroe I, Condliffe R: Pulmonary hypertension: Diagnosis and management. BMJ 2013, 346:f2028.
    • (2013) BMJ , vol.346 , pp. f2028
    • Kiely, D.G.1    Elliot, C.A.2    Sabroe, I.3    Condliffe, R.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.